Kinaxis Announces Normal Course Issuer Bid

Summary

• Kinaxis received TSX approval for a normal course issuer bid (NCIB) to purchase up to 2,698,037 common shares, representing approximately 10% of its public float as of October 31, 2026.
• The NCIB is effective for a 12-month period starting November 13, 2026, & ending November 12, 2027.
• Daily share purchases under the NCIB are capped at 28,119 shares, which equals 25% of the average daily trading volume for the six months ended October 31, 2026.
• All shares purchased under the NCIB will be canceled & the company has established an automatic share purchase plan (ASPP) to facilitate acquisitions during regulatory blackout periods.
• Under the previous bid expiring November 11, 2026, Kinaxis repurchased & canceled 1,537,232 shares at a weighted average price of approximately CDN $154.98 per share.
• The Board believes the share repurchases are a desirable use of corporate funds intended to benefit remaining shareholders by increasing their equity interest.